Wegovy pill: how the daily tablet is taken, and what changes from the pen

How the label says to take it

Section 2.1 of the prescribing information gives five instructions for the tablet, and the Medication Guide repeats them in plain language:

• One tablet, once a day, in the morning, on an empty stomach, with water: up to 4 ounces. No other liquid: not coffee, not juice.
• Swallow it whole. Do not split, crush, chew or dissolve it.
• Never more than one tablet a day.
• Then wait at least 30 minutes before eating, drinking anything else or taking other oral medicines.
• Keep it in its original bottle until you take it (more on storage below).

Four ounces is a US measure; it is roughly 120 mL, about half a standard glass. The label says "up to", so less is fine; it does not set a minimum.

Why the morning routine is so specific

The label's pharmacology section (12.3) explains the reasoning without turning it into advice. The tablet contains an absorption enhancer (SNAC), and semaglutide from the tablet is absorbed mainly in the stomach. In the studies it describes, absorption was higher with a small amount of water than with a large glass, and higher with a longer fast after the dose. That is why the instructions are about an empty stomach, a little water and a minimum wait. The label says "at least 30 minutes"; it does not tell you to wait longer, and how long you wait beyond that is a question for your prescriber, not for a forum.

One practical consequence: if you take other morning tablets, the same section of the label (and 7.2) says semaglutide can affect how some oral medicines are absorbed. Your pharmacist can tell you how to fit your other medicines around the 30 minutes.

Daily tablet or weekly pen: what actually changes

	Wegovy® tablet	Wegovy® pen
How often	Once daily	Once weekly, same day each week
Time and food	Morning, empty stomach, water only, then 30 minutes	Any time of day, with or without meals
Escalation counted in	Days (30-day steps)	Weeks (4-week steps)
Missed dose	Skip it; take the next one the following day	Take it if the next dose is more than 2 days away; otherwise skip
Storage	Room temperature, original bottle, dry	Refrigerator; limited time out of it

Source: Wegovy US prescribing information, sections 2.1–2.4 and 16 [1].

The weekly pen asks for one decision a week. The tablet asks for a small routine every morning, including weekends, travel days and mornings when you would rather have coffee first. Neither is easier for everyone; it depends on the shape of your days, which is worth telling your prescriber.

The steps the label lists

The prescribing information lists a starting strength and three increases, each lasting 30 days, before the maintenance strength. In the label's Table 2: 1.5 mg on days 1–30, 4 mg on days 31–60, 9 mg on days 61–90, and 25 mg from day 91. These are the label's steps, not a plan for you. The same section says that if a step is not tolerated, the prescriber may consider delaying the next one, and your prescriber decides when, and whether, you move. For every GLP-1 side by side, see the titration steps each label lists.

If you miss a tablet

The label is short here: skip the missed dose and take the next one the following day. The Medication Guide puts it as going back to your regular schedule for the next dose. Combined with "no more than one tablet per day", that means there is no catching up later in the day. This is the opposite of the pen, where a dose can still be taken if the next one is more than two days away. Every GLP-1's own rule is quoted in what each leaflet says about a missed dose. Missing several days in a row is a reason to call your prescriber, not to work out a restart yourself.

Storing the bottle

No refrigerator. The label says to store the tablets at 20–25 °C (68–77 °F), with short excursions between 15 and 30 °C allowed, in the original closed bottle until you are ready to take one, and in a dry place away from moisture. A weekly pill organiser is exactly what the Medication Guide rules out: "Do not store in any other container." That also makes a humid bathroom shelf a poor choice. For the pen's very different rules, see storing a GLP-1 pen.

Switching between the pen and the tablet

Section 2.5 of the US label describes switching in both directions, as instructions to the prescriber. From the pen to the tablet: someone on the 2.4 mg weekly injection may switch to the 25 mg tablet, starting it one week after stopping the injection. From the tablet to the pen: the weekly injection starts the day after the last 25 mg tablet. The label adds alternatives for people who did not tolerate the 25 mg tablet, which are your prescriber's to weigh. It also says using Wegovy together with other semaglutide products or any other GLP-1 receptor agonist is not recommended, so a switch means one or the other, not both at once.

Not every GLP-1 pill has the same rules

Two other oral semaglutide products, Ozempic® tablets and Rybelsus®, prescribed for type 2 diabetes, carry the same empty-stomach, small-sip, 30-minute instructions, and their shared label says they are not interchangeable milligram for milligram. Foundayo™ (orforglipron), a different molecule, is different again: its label says to take it once daily with or without food. So the morning routine belongs to oral semaglutide, not to "GLP-1 pills" in general. Read the instructions for the exact product in your hand.

Keeping one history across pen and tablet

A daily tablet produces seven entries a week instead of one, and the questions you get asked change with it: did you take it today, on which day did each step start, when did the last injection happen before the switch. Dozify logs tablets as daily doses; the Wegovy tablet strengths listed in its label are in the app's medication list, and dose reminders are free. Every entry keeps its date, so the day of your last injection and the day of your first tablet are both on record, which is the timing the switching section of the label is built around. The reminder on the lock screen never names the medicine.

One thing it deliberately does not do: Dozify draws no estimated medication-level curve for oral-only medicines. There is no oral profile in the app, and it does not invent one, because a wrong figure is worse than a blank one. The curve, a Premium estimate and never a measurement, is for injections; how the level estimate works explains its limits, and tracking a GLP-1 pill covers the tablet side.

Related reading

• GLP-1 dose schedule: the titration steps each label lists
• Missed a GLP-1 dose? What each leaflet says
• What is GLP-1?
• How much protein on a GLP-1, and how to reach it